Find out more about our ambitious upgrade project, delivering more brightness, more coherence, and greater speed of analysis to UK science. More about Diamond-II
Find out more about Diamond's response to virus research.
Plants have been used to produce a new vaccine against poliovirus in what is hoped to be a major step towards global eradication of the disease. The results are outlined in the journal Nature Communications “Plant-made Polio 3 stabilised VLPs - a candidate synthetic Polio vaccine.”
A collaborative team of many scientists led by Prof Dave Rowlands at the University of Leeds in collaboration with Dr Johanna Marsian and Prof George Lomonossoff from John Innes Centre, Prof Dave Stuart at University of Oxford and Director of Life Sciences at Diamond Light Source and Dr Andrew Macadam from The National Institute for Biological Standards and Control has developed a novel synthetic vaccine with a method grown in plants that uses virus-like particles (VLPs) – empty shells that trick immune system into a protective reaction. Genes that carry information to produce VLPs are infiltrated into the plant tissues. The host plant then reproduces large quantities of them using its own protein expression mechanisms.
The consortium was funded by the World Health Organisation and the Bill & Melinda Gates Foundation which are seeking alternative vaccines that avoid use of the live polio virus as part of an international drive to completely eradicate the disease worldwide.
The team turned to cryo-electron microscopy at Diamond’s Electron Bio-Imaging Centre (eBIC) to obtain a clear look at the structure of the empty shells. They confirmed the structure and showed that the external features of the new synthetic vaccine were identical to those of the poliovirus albeit it had not viral materials within to trigger actual infection. This means that they achieve a protective reaction by stimulating the immune system to respond without causing an infection of poliomyelitis as they do not contain the infectious material that allows viruses to replicate.
Dave Rowlands, Emeritus Professor of Virology at the University of Leeds and Principal Investigator on this project, said, “Small scale laboratory tests demonstrated that the ground-breaking synthetic vaccine provided animals with immunity from the disease similar to the existing widely used vaccine. Although this is still early results, it does provide evidence that this can be taken to the next stage with input of pharmaceutical industry collaborators.
“The results of our research pave the way towards production of a novel synthetic vaccine to help bring about the global elimination of poliomyelitis. Such a vaccine would be quicker, easier and safer to produce, without the inherent danger of accidental release of virus associated with the production of current vaccines.”
The breakthrough was made by employing technology that helped in the design of a new synthetic vaccine to combat the foot and mouth disease virus (FMDV) to target the virus that causes polio.
Dave Stuart, Director of Life Sciences at Diamond and Professor of Structural Biology at University of Oxford explains, “We were inspired by the successful synthetic vaccine for foot-and-mouth disease, also investigated at Diamond as part of UK research collaboration. By using Diamond’s visualisation capabilities and the expertise of Oxford University in structural analysis and computer simulation, we were able to visualise something a billion times smaller than a pinhead and further enhance the design atom by atom of the empty shells. Through information gained at Diamond, we also verified that these have essentially the same structure as the native virus to ensure an appropriate immune response.”
Prof Lomonossoff, from the John Innes Centre said: “This is an incredible collaboration involving plant science, animal virology and structural biology. The question for us now is how to scale it up - we don’t want to stop at a lab technique.”
“The beauty of this system of growing non-pathogenic virus mimics in plants, is that it boosts our ability to scale-up the production of vaccine candidates to combat emerging threats to human health,” said Prof Lomonossoff.
To find out more, please see our Science Highlight.
Please visit the John Innes Centre (JIC) site for futher details on their major role in this breakthrough.
Diamond Light Source is the UK's national synchrotron science facility, located at the Harwell Science and Innovation Campus in Oxfordshire.
Copyright © 2022 Diamond Light Source
Diamond Light Source Ltd
Harwell Science & Innovation Campus
Diamond Light Source® and the Diamond logo are registered trademarks of Diamond Light Source Ltd
Registered in England and Wales at Diamond House, Harwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0DE, United Kingdom. Company number: 4375679. VAT number: 287 461 957. Economic Operators Registration and Identification (EORI) number: GB287461957003.